RECMGMT-L Archives

Records Management

RECMGMT-L@LISTSERV.IGGURU.US
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Content-Type:
text/plain; charset="us-ascii"
Date:
Mon, 7 May 2012 15:47:06 +0000
Reply-To:
Records Management Program <[log in to unmask]>
Subject:
Re: Drug Trial Retention?
From:
Barbara Wyton <[log in to unmask]>
Content-Transfer-Encoding:
8bit
In-Reply-To:
<000d01cd2c67$494d78c0$dbe86a40$@[log in to unmask]>
MIME-Version:
1.0
Sender:
Records Management Program <[log in to unmask]>
Parts/Attachments:
text/plain (21 lines) 
Hi Charlie,

Yes, this requirement is only for trials conducted in Canada.   However, I should mention that GSK as a whole has determined an even longer timeframe for their clinical trial data worldwide.   Note, this should not be confused with pre-clinical research data.    As Nancy Freeman mentioned,  pre-clinical research data can be shelved and then revived many years later.


Barb


Barbara Wyton
Records Management Specialist
GLAXOSMITHKLINE
7333 Mississauga Rd
Mississauga, Ontario  L5N 6L4
(direct) 905-819-7050
(fax) 905-819-3099

List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance
To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]

ATOM RSS1 RSS2